- Home
- EPM vs CRVO Comparison
EPM vs CRVO Comparison
Compare EPM & CRVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EPM
- CRVO
- Stock Information
- Founded
- EPM 2003
- CRVO 2001
- Country
- EPM United States
- CRVO United States
- Employees
- EPM N/A
- CRVO N/A
- Industry
- EPM Oil & Gas Production
- CRVO Biotechnology: Pharmaceutical Preparations
- Sector
- EPM Energy
- CRVO Health Care
- Exchange
- EPM Nasdaq
- CRVO Nasdaq
- Market Cap
- EPM 171.8M
- CRVO 160.4M
- IPO Year
- EPM 1996
- CRVO N/A
- Fundamental
- Price
- EPM $5.48
- CRVO $17.61
- Analyst Decision
- EPM Strong Buy
- CRVO Strong Buy
- Analyst Count
- EPM 1
- CRVO 5
- Target Price
- EPM $8.25
- CRVO $57.60
- AVG Volume (30 Days)
- EPM 316.1K
- CRVO 85.0K
- Earning Date
- EPM 09-10-2024
- CRVO 11-11-2024
- Dividend Yield
- EPM 8.44%
- CRVO N/A
- EPS Growth
- EPM N/A
- CRVO N/A
- EPS
- EPM 0.12
- CRVO N/A
- Revenue
- EPM $85,877,000.00
- CRVO $9,653,281.00
- Revenue This Year
- EPM $28.11
- CRVO $47.04
- Revenue Next Year
- EPM N/A
- CRVO N/A
- P/E Ratio
- EPM $46.75
- CRVO N/A
- Revenue Growth
- EPM N/A
- CRVO 585.67
- 52 Week Low
- EPM $4.59
- CRVO $4.28
- 52 Week High
- EPM $7.07
- CRVO $26.38
- Technical
- Relative Strength Index (RSI)
- EPM 62.41
- CRVO 55.90
- Support Level
- EPM $5.37
- CRVO $15.68
- Resistance Level
- EPM $5.82
- CRVO $19.50
- Average True Range (ATR)
- EPM 0.21
- CRVO 1.94
- MACD
- EPM 0.09
- CRVO 0.09
- Stochastic Oscillator
- EPM 90.39
- CRVO 54.75
About EPM Evolution Petroleum Corporation Inc.
Evolution Petroleum Corp is an independent oil and gas company operating in the US. It is engaged primarily in the acquisition, exploitation, and development of properties for the production of crude oil and natural gas, onshore in the United States. The company's revenues are primarily generated from its crude oil, natural gas and NGL production from the Jonah Field in Sublette County, Wyoming; the Williston Basin in North Dakota; the Barnett Shale located in North Texas; the Hamilton Dome Field in Wyoming; and the Delhi Field in Northeast Louisiana. The revenue generated by the company includes royalty, mineral and working interests.
About CRVO CervoMed Inc.
CervoMed Inc is a clinical-stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.